Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 175

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Ventricular Arrhythmias in the North American Multidisciplinary Study of ARVC

Open access
Link, Mark S., Laidlaw, Douglas, Polonsky, Bronislava, Zareba, Wojciech, McNitt, Scott, Gear, Kathleen, Marcus, Frank, Estes, N. A. Mark · 2014 · Journal of the American College of Cardiology

Abstract

BACKGROUND Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with sudden cardiac death. However, the selection of patients for implanted cardioverter-defibrillators (ICDs), as well as programming of the ICD, is unclear. OBJECTIVES The objective of this study was to identify predictors, characteristics, and treatment of ventricular arrhythmias in patients with ARVC. METHODS The Multidisciplinary Study of Right Ventricular Cardiomyopathy established the North American ARVC Registry and enrolled patients with a diagnosis of ARVC. Patients were followed prospectively. RESULTS Of 137 patients enrolled, 108 received ICDs. Forty-eight patients had 502 sustained episodes of ventricular arrhythmias, including 489 that were monomorphic and 13 that were polymorphic. In the patients with ICDs, independent predictors of ventricular arrhythmias in follow-up included spontaneous sustained ventricular arrhythmias before ICD implantation and T-wave inversions inferiorly. The only independent predictor for life-threatening arrhythmias, defined as sustained ventricular tachycardia (VT) ≥240 beats/min or ventricular fibrillation, was a younger age at enrollment. Anti-tachycardia pacing (ATP), independent of the cycle length of the VT, was successful in terminating 92% of VT episodes. CONCLUSIONS In the North American ARVC Registry, the majority of ventricular arrhythmias in follow-up are monomorphic. Risk factors for ventricular arrhythmias were spontaneous ventricular arrhythmias before enrollment and a younger age at ICD implantation. ATP is highly successful in terminating VT, and all ICDs should be programmed for ATP, even for rapid VT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2014.04.035

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 13

  1. Basso, 2009, Arrhythmogenic right ventricular cardiomyopathy, Lancet, 373, 1289, 10.1016/S0140-6736(09)60256-7 · DOI · Paper page
  2. Marcus, 2009, Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study, Heart Rhythm, 6, 984, 10.1016/j.hrthm.2009.03.013 · DOI · Paper page
  3. Marcus, 1995, Arrhythmogenic right ventricular dysplasia/cardiomyopathy: a review, Pacing Clin Electrophysiol, 18, 1298, 10.1111/j.1540-8159.1995.tb06971.x · DOI · Paper page
  4. Wichter, 2004, Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients, Circulation, 109, 1503, 10.1161/01.CIR.0000121738.88273.43 · DOI · Paper page
  5. Roguin, 2004, Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy, J Am Coll Cardiol, 43, 1843, 10.1016/j.jacc.2004.01.030 · DOI · Paper page
  6. Nava, 2000, Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy, J Am Coll Cardiol, 36, 2226, 10.1016/S0735-1097(00)00997-9 · DOI · Paper page
  7. Corrado, 2003, Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia, Circulation, 108, 3084, 10.1161/01.CIR.0000103130.33451.D2 · DOI · Paper page
  8. Marcus, 2003, Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a multidisciplinary study: design and protocol, Circulation, 107, 2975, 10.1161/01.CIR.0000071380.43086.29 · DOI
  9. Marcus, 2009, Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry, J Am Coll Cardiol, 54, 609, 10.1016/j.jacc.2009.04.052 · DOI · Paper page
  10. Link, 1997, Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators, J Interv Card Electrophysiol, 1, 41, 10.1023/A:1009714718034 · DOI
  11. Peters, 2007, Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres, J Cardiovasc Med, 8, 521, 10.2459/01.JCM.0000278450.35107.b3 · DOI
  12. Lemola, 2005, Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre, Heart, 91, 1167, 10.1136/hrt.2004.038620 · DOI
  13. Ellenbogen, 2006, Are implantable cardioverter-defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?, Circulation, 113, 776, 10.1161/CIRCULATIONAHA.105.561571 · DOI · Paper page

Cited by

See all 175

Metadata

Authors
Link, M. S., Laidlaw, D., Polonsky, B., Zareba, W., McNitt, S., Gear, K., Marcus, F., & Estes, N. A. M.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2014-07
Volume
64
Issue
2
Pages
119-125
ISSN
0735-1097 (ISSN-L)
OpenAlex
W165652168
Cited by
175
References
2
FWCI
12.85
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ventricular Arrhythmias in the North American Multidisciplinary Study of ARVC. https://app.cochat.ai/papers/10.1016/j.jacc.2014.04.035
The paper
Link, M. S., Laidlaw, D., Polonsky, B., Zareba, W., McNitt, S., Gear, K., Marcus, F., & Estes, N. A. M. (2014). Ventricular Arrhythmias in the North American Multidisciplinary Study of ARVC. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2014.04.035

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.